TSPO and neoplasm: Molecular imaging studies with the TSPO PET ligand [18F]PBR06 revealed selective and targeted uptake not only in engrafted tumor, but infiltrative growth in the opposite hemisphere previously undetected by our T2-weighted MRI scans.